SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 571.97 |
| Enterprise Value ($M) | 478.43 |
| Book Value ($M) | 721.08 |
| Book Value / Share | 4.23 |
| Price / Book | 0.79 |
| NCAV ($M) | 661.38 |
| NCAV / Share | 3.88 |
| Price / NCAV | 0.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.43 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.96 |
| Current Ratio | 19.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 739.66 |
| Assets | 799.36 |
| Liabilities | 78.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 10.01 |
| Operating Income | -385.67 |
| Net Income | -337.71 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -249.11 |
| Cash from Investing | -41.08 |
| Cash from Financing | 270.15 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Commodore Capital Lp | 5.80 | ||
| 13G/A | Vanguard Group Inc | 7.14 | 13.66 | |
| 13G/A | BlackRock, Inc. | 6.10 | -29.75 | |
| 13G | Point72 Asset Management, L.P. | 5.70 | ||
| 13G/A | Price T Rowe Associates Inc /md/ | 3.30 | -38.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 237,607 | 1,631,066 | 14.57 | |
| 270,586 | 958,787 | 28.22 | |
| 224,340 | 1,007,133 | 22.28 | |
| 316,356 | 1,365,878 | 23.16 | |
| 413,938 | 1,423,362 | 29.08 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RANI – Rani Therapeutics Holdings, Inc. | RAPT – RAPT Therapeutics, Inc. |
| RCKT – Rocket Pharmaceuticals, Inc. | RNA – Avidity Biosciences, Inc. |
| RNAC – Cartesian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io